SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANRG -- Anergen -- new CEO big chance ? -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (115)12/14/1998 12:31:00 PM
From: Cacaito  Read Replies (1) | Respond to of 123
 
Corixa seems to understand T cells science, Anergen programs are idle due to lack of cash. Do they have cash?

I am glad they took the company. Otherwise it was going to be 5 cents soon.



To: WWS who wrote (115)12/17/1998 1:35:00 AM
From: Steve Harmon  Respond to of 123
 
Bill,
Being that Anrg has $0 cash it doesn't seem such a bad deal for ANRG shareholders that they are getting SOMETHING for their shares.

CRXA mgt. seems aggressive.

Steve



To: WWS who wrote (115)12/17/1998 1:52:00 AM
From: Steve Harmon  Read Replies (1) | Respond to of 123
 
Bill,

For crxa it seems a good deal in that they paid for it in stock instead of cash.

steve


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News